Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART

BACKGROUND: Treatment options are limited for TB/HIV-coinfected children who require PI-based ART. Rifabutin is the preferred rifamycin for adults on PIs, but the one study evaluating rifabutin with PIs among children was stopped early due to severe neutropenia. METHODS: We evaluated rifabutin safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawizza, Holly E, Oladokun, Regina, Ejeliogu, Emeka, Oguche, Stephen, Ogunbosi, Babatunde O, Agbaji, Oche, Odaibo, Georgina, Imade, Godwin, Olaleye, David, Wiesner, Lubbe, Darin, Kristin M, Okonkwo, Prosper, Kanki, Phyllis J, Scarsi, Kimberly K, McIlleron, Helen M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879135/
https://www.ncbi.nlm.nih.gov/pubmed/33294914
http://dx.doi.org/10.1093/jac/dkaa512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879135/
https://www.ncbi.nlm.nih.gov/pubmed/33294914
http://dx.doi.org/10.1093/jac/dkaa512

Ejemplares similares